{"entity":{"id":"benchsci","kind":"company","name":"BenchSci","aka":[],"tldr":"BenchSci develops research software that proposes drug targets and combinations, including early laboratory work in lung cancer.","summary":"BenchSci's Emet research software combines biomedical information to propose therapeutic hypotheses. A company report describes testing four proposals in human lung squamous cell carcinoma cells and reports that two combinations produced effects exceeding the individual agents. This is company-reported, early laboratory work. It does not demonstrate that the combinations are safe or effective treatments for people.","asOf":"2026-11-06","links":[{"label":"Lung cancer hypothesis-generation research","url":"https://www.benchsci.com/news/introducing-the-hypothesis-generation-agent"},{"label":"Official location evidence","url":"https://www.benchsci.com/contact"},{"label":"Elicit AI for Pharma market map","url":"https://elicit.com/ai-for-pharma"}],"tags":[],"related":[],"cancers":[],"sections":["drug-discovery","ai-computation"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Location is the company's published contact address."],"hq":"Toronto, ON","country":"CA","companyType":"ai-software","website":"https://www.benchsci.com/","investors":[],"funding":[]},"route":"/companies/benchsci/","neighbours":{"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"collection":[{"id":"elicit-ai-for-pharma","kind":"collection","name":"Elicit AI for Pharma market map","route":"/collections/elicit-ai-for-pharma/"}]}}